News
Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...
TrialWire™ is the risk-share pay-per-enrolled AI and algorithm-powered patient recruitment Platform built on Salesforce ...
Being able to adapt to your environment is critical to survival. That’s what Charles Darwin discovered when he developed the ...
Oslo, 20 May 2025. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter ...
The gene editing company CRISPR Therapeutics surprisingly struck a deal with China-based biotech Sirius Therapeutics to ...
Smithfield lease Mass. biotech offered millions to manufacture skin in R.I. Boston biotech aims to put some skin in the RI ...
Explore more
The trial of seven health professionals accused of negligence in the death of Diego Maradona was suspended for a week on ...
Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...
In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...
Schrödinger is laying off 60 staffers, or about 7% of its workforce, in an effort to save cash and boost efficiency. | ...
A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility ...
"While the rescinded grant is undoubtedly a setback, it also sharpens our focus on the solid foundation already established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results